# SORBITOL

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid5023588
Categories: beauty, cleaning, food, industrial, pharma
Functions: Biocide, Crystal growth modifiers (nucleating agents), Delivery vehicle, Flavouring and nutrient, Fragrance, Humectant, Plasticizer, Processing aids not otherwise specified, Softener and conditioner, Stabilizing agent, Thickening agent, polyurethanes>polyols
Identifier: DTXSID5023588

> SORBITOL is used as biocide / crystal growth modifiers (nucleating agents). EPA CPDat observed this chemical in 3516 composition records across product categories including Personal care, Pet and animal care, Food and drug. Assessed from 51 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 3516 composition records across product categories including Personal care, Pet and animal care, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 3516 composition records across product categories including Personal care, Pet and animal care, Food and drug. EPA CPDat classifies this chemical for functional uses including Humectant, Delivery vehicle, Flavouring and nutrient.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 5110 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE; Potency: 14.6 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 14 %w/w
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 45 %w/v
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 45 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: NA
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: 45 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1200 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 1.04 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 4050 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 25 mg/1ml
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 49 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.25 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 744 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 600 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 833.3 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 6168 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 53460 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 36000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 12000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 29268 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Potency: 300 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 45000 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 4370 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 337.28 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 3555 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 12.96 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 0.01 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 428 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SUSPENSION; Potency: 46.18 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 4.7 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 4.7 %w/v
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 50.5 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 4.95 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 36.8 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Potency: 15 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 7 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LIQUID; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 10.7 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 10 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 6300 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 12 active drug products and 15 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._